EP1501870A4 - Rsv proteine, antikörper, zusammensetzungen, verfahren und verwendungen - Google Patents

Rsv proteine, antikörper, zusammensetzungen, verfahren und verwendungen

Info

Publication number
EP1501870A4
EP1501870A4 EP02806688A EP02806688A EP1501870A4 EP 1501870 A4 EP1501870 A4 EP 1501870A4 EP 02806688 A EP02806688 A EP 02806688A EP 02806688 A EP02806688 A EP 02806688A EP 1501870 A4 EP1501870 A4 EP 1501870A4
Authority
EP
European Patent Office
Prior art keywords
antibodies
compositions
methods
rsv proteins
rsv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02806688A
Other languages
English (en)
French (fr)
Other versions
EP1501870A2 (de
Inventor
Bernard Scallon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor Inc filed Critical Centocor Inc
Publication of EP1501870A2 publication Critical patent/EP1501870A2/de
Publication of EP1501870A4 publication Critical patent/EP1501870A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/11—Paramyxoviridae (F); Pneumoviridae (F), e.g. respiratory syncytial virus [RSV]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP02806688A 2001-11-02 2002-10-26 Rsv proteine, antikörper, zusammensetzungen, verfahren und verwendungen Withdrawn EP1501870A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33608101P 2001-11-02 2001-11-02
US336081P 2001-11-02
US33783801P 2001-11-13 2001-11-13
US337838P 2001-11-13
PCT/US2002/034154 WO2003063767A2 (en) 2001-11-02 2002-10-26 Rsv proteins, antibodies, compositions, methods and uses

Publications (2)

Publication Number Publication Date
EP1501870A2 EP1501870A2 (de) 2005-02-02
EP1501870A4 true EP1501870A4 (de) 2006-05-03

Family

ID=27668884

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02806688A Withdrawn EP1501870A4 (de) 2001-11-02 2002-10-26 Rsv proteine, antikörper, zusammensetzungen, verfahren und verwendungen

Country Status (6)

Country Link
EP (1) EP1501870A4 (de)
JP (1) JP2005522996A (de)
AU (1) AU2002365925A1 (de)
CA (1) CA2466025A1 (de)
MX (1) MXPA04004224A (de)
WO (1) WO2003063767A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1176195E (pt) 1999-04-09 2013-07-18 Kyowa Hakko Kirin Co Ltd Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
US8496930B2 (en) 2003-10-01 2013-07-30 Kyowa Hakko Kirin Co., Ltd Method of stabilizing antibody and stabilized solution-type antibody preparation
JP5575377B2 (ja) 2008-07-18 2014-08-20 シスメックス株式会社 抗ｒｓウイルスモノクローナル抗体を用いたｒｓウイルス検出用キット及びイムノクロマトグラフィー用試験具、並びに新規な抗ｒｓウイルスモノクローナル抗体

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840298A (en) * 1995-06-07 1998-11-24 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
WO2001064751A2 (en) * 2000-03-01 2001-09-07 Medimmune, Inc. High potency recombinant antibodies and method for producing them

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0671927T3 (da) * 1992-09-16 2003-04-22 Us Gov Health & Human Serv Neutraliserende humane monoklonale antistoffer mod respiratorisk syncytialvirus
CA2270288A1 (en) * 1996-11-01 1998-05-14 Smithkline Beecham Corporation Human monoclonal antibodies

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840298A (en) * 1995-06-07 1998-11-24 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
WO2001064751A2 (en) * 2000-03-01 2001-09-07 Medimmune, Inc. High potency recombinant antibodies and method for producing them

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
BARBAS CARLOS F III ET AL: "Human monoclonal Fab fragments derived from a combinatorial library bind to respiratory syncytial virus F glycoprotein and neutralize infectivity", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, vol. 89, no. 21, 1992, pages 10164 - 10168, XP002369927, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
EP1501870A2 (de) 2005-02-02
JP2005522996A (ja) 2005-08-04
WO2003063767A3 (en) 2004-12-02
AU2002365925A1 (en) 2003-09-02
CA2466025A1 (en) 2003-08-07
MXPA04004224A (es) 2005-03-31
WO2003063767A2 (en) 2003-08-07

Similar Documents

Publication Publication Date Title
EP1562968A4 (de) Anti-il-6-antikörper, zusammensetzungen, verfahren und anwendungen
EP1396500A4 (de) Anti-trail-r-antikörper
EP1660638A4 (de) Lipopartikel umfassende proteine, verfahren zur herstellung und verwendung davon
CY2019029I2 (el) Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις
EP1536828A4 (de) Verfahren für die zuführung exogener proteine in das zytosol und verwendungen davon
EP1423431A4 (de) Antikörper gegen vla-1
EP1551877A4 (de) Taci-antikörper und deren verwendung
FR09C0021I2 (fr) Anticorps, compositions, procedes anti-il-12 et leur utilisation
EP1572881A4 (de) Polypeptide tacis und br3 sowie verwendungen davon
EP1470159A4 (de) Antikörper gegen latente membranproteine und verwendungen davon
EP1517724A4 (de) Antiangiogene proteine und fragmente sowie verfahren zur verwendung davon
EP1581641A4 (de) Zusammensetzungen, spleissvarianten undverfahren in verbindung mit ovarialspezifischen genen und proteinen
NO20032587D0 (no) ABCA-1 eleverende forbindelser
IS6881A (is) Samsett fjölgilt fjölsykru-próteinbóluefni gegn heilasóttarhnettlu
MA30684B1 (fr) Anticorps anti-mn et leurs procedes d'utilisation.
MA27036A1 (fr) Ligands des recepteurs de 5-ht et leurs utilisations
EP1616881A4 (de) Anti-mpl-antikörper
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
EP1435946A4 (de) Verknüpfte biaryl-verbindungen
EP1294513A4 (de) Lokalisationsspezifische kovalente biokonjugation von proteinen
DE60117032D1 (de) Glasfaserspleissverstärkung
EP1699485A4 (de) Anti-hydrolysat-antikörper und ihre verwendungen
FR2819410B1 (fr) Composition cosmetique irisee et ses utilisations
DE60332711D1 (de) Neue insektizide proteine von bazillus thuringiensis
EE200300569A (et) CD44v6-spetsiifilised antikehad

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040601

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20060320

17Q First examination report despatched

Effective date: 20060706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061117